ReviewPolymer science & technology (Washington, D.C.)2026
Organic Semiconducting Polymers for Cancer Sonodynamic Immunotherapy.
Review in Polymer science & technology (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- NIR-II conjugated polymers for tumor sonodynamic therapy.Discover nano · 2026Review
- Engineering Polymeric Nano-PROTAC for Targeted Protein Degradation and Cancer Therapy.Polymer science & technology (Washington, D.C.) · 2026Review
- Spatiotemporal Nanotransformers for Antitumoral Orchestration of Protein Homeostasis.Polymer science & technology (Washington, D.C.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer immunotherapy has attracted significant attention in recent years for its ability to harness the patient's own immune system to target and eliminate tumors. Despite its promise, major challenges remain, including low tumor immunogenicity, immunosuppressive tumor microenvironments, and systemic toxicities. To address these issues, activatable immunotherapy strategies have been developed, enabling the precise activation of immune agents in response to specific endogenous or exogenous signals. Among these approaches, ultrasound-triggered sonodynamic therapy (SDT) has emerged as a promising non-invasive modality, offering deep tissue penetration and spatiotemporal precision. Organic semiconducting polymers (SPs), as a class of sonosensitizers, exhibit excellent acoustic responsiveness, biocompatibility, and structural tunability, making them ideal candidates for tumor-targeted SDT. This Review highlights recent advances in the application of organic semiconducting polymers in cancer immunotherapy, discusses current challenges, and explores future directions for developing more precise and low-toxicity therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.